Chemed CHE unveils its next round of earnings this Wednesday, July 29. Get prepared with Benzinga's ultimate preview for Chemed's Q2 earnings.
Earnings and Revenue
Chemed EPS is expected to be around $3.75, according to sell-side analysts. Sales will likely be near $522.89 million. In the same quarter last year, Chemed posted EPS of $3.360 on sales of $473.58 million. The Wall Street consensus estimate for earnings would represent a 11.61% increase for the company. Revenue would be up 0.52% on a year-over-year basis. Here's how the company's EPS has stacked up against analyst estimates in the past:
| Quarter | Q1 2020 | Q4 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|
| EPS Estimate | 3.65 | 4.09 | 3.31 | 3.11 |
| EPS Actual | 3.68 | 4.22 | 3.46 | 3.36 |
| Revenue Estimate | 520.18 M | 524.19 M | 478.89 M | 471.72 M |
| Revenue Actual | 515.80 M | 522.32 M | 480.61 M | 473.58 M |
Stock Performance
Shares of Chemed were trading at $469.79 as of July 28. Over the last 52-week period, shares are up 14.62%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.
Don't be surprised to see the stock move on comments made during its conference call. Chemed is scheduled to hold the call at 10:00:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/7wjfjb5w
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
